Genes and networks expressed in perioperative omental adipose tissue are correlated with weight loss from Roux-en-Y gastric bypass

International Journal of Obesity

Volumn 32, Issue 9, 2008, Pages 1395-1406

  Kim, K ^a,b   Perroud, B ^a   Espinal, G ^a   Kachinskas, D ^a   Austrheim Smith, I ^c   Wolfe, B M ^c   Warden, C H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gastric bypass surgery; Gene expression analysis; Perioperative adipose tissue; Postoperative weight reduction

Indexed keywords

ACYL COENZYME A OXIDASE; AMP ACTIVATED PROTEIN KINASE BETA 1 NON CATALYTIC SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IIIA; PROTEIN KINASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; OBESITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PURINE METABOLISM; RNA ISOLATION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

ABDOMINAL FAT; ADOLESCENT; ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY WEIGHT; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; GASTRIC BYPASS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; OBESITY, MORBID; OMENTUM; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 51849087593     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.106     Document Type: Article

References (65)

1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Bodymass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
2. Belle SH, Berk PD, Courcoulas AP, Flum DR, Miles CW, Mitchell JE, et al., LABS Consortium Writing Group. Safety and efficacy of bariatric surgery: longitudinal assessment of Bariatric surgery. Surg Obes Relat Dis 2007; 3: 116-126.
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
4. Larsson SC, Wolk A. Excess body fatness: an important cause of most cancers. Lancet 2008; 371: 536-537.
5. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H et al. Swedish obese subjects study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.
6. Gastrointestinal Surgery for Severe Obesity. NIH Consensus Statement 1991 Mar 25-27; 9: 1-20.
7. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761.
8. Mitchell JE, Lancaster KL, Burgard MA, Howell LM, Krahn DD, Crosby RD et al. Long-term follow-up of patients' status after gastric bypass. Obes Surg 2001; 11: 464-468.
9. MacLean LD, Rhode BM, Shizgal HM. Nutrition following gastric operations for morbid obesity. Ann Surg 1983; 198: 347-355.
10. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-1630.
11. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108-114.
12. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity 2006; 14: 1553-1561.
13. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA 2000; 97: 11371-11376.
14. Xu Y, Ramos EJ, Middleton F, Romanova I, Quinn R, Chen C et al. Gene expression profiles post Roux-en-Y gastric bypass. Surgery 2004; 136: 246-252.
15. Trivedi P, Edwards JW, Wang J, Gadbury GL, Srinivasasainagendra V, Zakharkin SO et al. HDBStat!: a platform-independent software suite for statistical analysis of high dimensional biology data. BMC Bioinformatics 2005; 6: 86.
16. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 31-36.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57: 289-300.
18. Allison DB, Gadbury GL, Heo M, Fernández JR, Lee C, Prolla TA et al. A mixture model approach for the analysis of microarray gene expression data. Comput Stat Data Anal 2002; 39: 1-20.
19. Rossmeisl M, Flachs P, Brauner P, Sponarova J, Matejkova O, Prazak T et al. Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores. Int J Obes Relat Metab Disord 2004; 28 (Suppl 4): S38-S44.
20. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 2006; 116: 1776-1783.
21. Löbbert RW, Winterpacht A, Seipel B, Zabel BU. Molecular cloning and chromosomal assignment of the human homologue of the rat cGMP-inhibited phosphodiesterase 1 (PDE3A)- a gene involved in fat metabolism located at 11p 15.1. Genomics 1996; 37: 211-218.
22. Pereira RM, Aguiar-Oliveira MH, Sagazio A, Oliveira CR, Oliveira FT, Campos VC et al. Heterozygosity for a mutation in the growth hormone-releasing hormone receptor gene does not influence adult stature, but affects body composition. J Clin Endocrinol Metab 2007; 92: 2353-2357.
23. Tanizawa Y, Nakai K, Sasaki T, Anno T, Ohta Y, Inoue H et al. Unregulated elevation of glutamate dehydrogenase activity induces glutamine-stimulated insulin secretion: identification and characterization of a GLUD1 gene mutation and insulin secretion studies with MIN6 cells overexpressing the mutant glutamate dehydrogenase. Diabetes 2002; 51: 712-717.
24. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human Secretor blood group alpha(1,2) fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 1995; 270: 4640-4649.
25. Roos C, Kolmer M, Mattila P, Renkonen R. Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. J Biol Chem 2002; 277: 3168-3175.
26. Vantyghem MC, Fajardy I, Dhondt F, Girardot C, D'Herbomez M, Danze PM et al. Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department. Eur J Endocrinol 2006; 154: 835-841.
27. Farahani P, Chiu S, Bowlus CL, Boffelli D, Lee E, Fisler JS et al. Obesity in BSB mice is correlated with expression of genes for iron homeostasis and leptin. Obes Res 2004; 12: 191-204.
28. Rose AJ, Hargreaves M. Exercise increases Ca2+-calmodulindependent protein kinase II activity in human skeletal muscle. J Physiol 2003; 553: 303-309.
29. Papadimitriou GN, Dikeos DG, Karadima G, Avramopoulos D, Daskalopoulou EG, Vassilopoulos D et al. Association between the GABA(A) receptor alpha5 subunit gene locus (GABRA5) and bipolar affective disorder. Am J Med Genet 1998; 81: 73-80.
30. Otani K, Ujike H, Tanaka Y, Morita Y, Katsu T, Nomura A et al. The GABA type A receptor alpha5 subunit gene is associated with bipolar I disorder. Neurosci Lett 2005; 381: 108-113.
31. Souza FG, Mander AJ, Foggo M, Dick H, Shearing CH, Goodwin GM. The effects of lithium discontinuation and the non-effect of oral inositol upon thyroid hormones and cortisol in patients with bipolar affective disorder. Affect Disord 1991; 22: 165-170.
32. Robinson JK, Bartfai T, Langel U. Galanin/GALP receptors and CNS homeostatic processes. CNS Neurol Disord Drug Targets 2006; 5: 327-334.
33. Vrontakis ME. Galanin: a biologically active peptide. Curr Drug Targets CNS Neurol Disord 2002; 1: 531-541.
34. Novak G, Seeman P, Tallerico T. Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse 2006; 59: 61-68.
35. Münch G, Bölck B, Karczewski P, Schwinger RH. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium. J Mol Cell Cardiol 2002; 34: 321-334.
36. Lemos MC, Kotanko P, Christie PT, Harding B, Javor T, Smith C et al. A novel EXT1 splice site mutation in a kindred with hereditary multiple exostosis and osteoporosis. J Clin Endocrinol Metab 2005; 90: 5386-5392.
37. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003; 144: 5081-5088.
38. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 2004; 89: 6208-6217.
39. Chen HY, Chen WC, Wu MC, Tsai FJ, Tsai CH. Androgen receptor (AR) gene microsatellite polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Eur J Obstet Gynecol Reprod Biol 2003; 107: 52-56.
40. Magklara A, Brown TJ, Diamandis EP. Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. Int J Cancer 2002; 100: 507-514.
41. Kominea A, Konstantinopoulos PA, Kapranos N, Vandoros G, Gkermpesi M, Andricopoulos P et al. Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer. J Cancer Res Clin Oncol 2004; 130: 253-258.
42. Leung JK, Pereira-Smith OM. Identification of genes involved in cell senescence and immortalization: potential implications for tissue ageing. Novartis Found Symp 2001; 235: 105-110; discussion 110-5; 146-9.
43. Pena AN, Pereira-Smith OM. The role of the MORF/MRG family of genes in cell growth, differentiation, DNA repair, and thereby aging. Ann N Y Acad Sci 2007; 1100: 299-305.
44. Schultz K, Rasmussen LM, Ledet T. Expression levels and functional aspects of the hyaluronan receptor CD44. Effects of insulin, glucose, IGF-I, or growth hormone on human arterial smooth muscle cells. Metabolism 2005; 54: 287-295.
45. Katoh M. Regulation of WNT3 and WNT3A mRNAs in human cancer cell lines NT2, MCF-7, and MKN45. Int J Oncol 2002; 20: 373-377.
46. Chiba H, Kobune M, Kato J, Kawano Y, Ito Y, Nakamura K et al. Wnt3 modulates the characteristics and cobblestone area-supporting activity of human stromal cells. Exp Hematol 2004; 32: 1194-1203.
47. Garcia-Barceló MM, LeeWS, Sham MH, Lui VC, Tam PK. Is there a role for the IHH gene in Hirschsprung's disease? Neurogastroenterol Motil 2003; 15: 663-668.
48. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425: 846-851.
49. van den Brink GR, Bleuming SA, Hardwick JC, Schepman BL, Offerhaus GJ, Keller JJ et al. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet 2004; 36: 277-282.
50. Jin C, Ding P,Wang Y, Ma D. Regulation of EGF receptor signaling by the MARVEL domain-containing protein CKLFSF8. FEBS Lett 2005; 579: 6375-6382.
51. Birger Y, Catez F, Furusawa T, Lim JH, Prymakowska-Bosak M, West KL et al. Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1. Cancer Res 2005; 65: 6711-6718.
52. Yasuda M, Nakano K, Yasumoto K, Tanaka Y. CD44: functional relevance to inflammation and malignancy. Histol Histopathol 2002; 17: 945-950.
53. Jayan GC, Casey JL. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J Virol 2002; 76: 12399-12404.
54. Elshatorya Y, Brooksb AI, Chattopadhyaya CS, Currana TM, Guptad P, Ramalingamd V et al. Changes in gene expression in two models of batten disease. FEBS Let 2003; 538: 207-212.
55. Pilane CM, LaBelle EF. cPLA2 activator peptide, PLAP, increases arachidonic acid release and apoptosis of vascular smooth muscle cells. J Cell Physiol 2004; 198: 48-52.
56. Okumura Y, Mizushimab H, Sunamoto J. Relocation of active acetylcholinesterase to liposome-gel conjugate. J Colloid Interface Sci 2007; 307: 296-299.
57. de Vet EC, Ijlst L, Oostheim W, Dekker C, Moser HW, van den Bosch H et al. Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. J Biol Chem 1998; 273: 10296-10301.
58. Hsu LC, Chang WC, Yoshida A. Cloning of a cDNA encoding human ALDH7, a new member of the aldehyde dehydrogenase family. Gene 1994; 151: 285-289.
59. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006; 14: 529-644.
60. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo Vet al. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003; 422: 297-302.
61. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008; 452: 429-435.
62. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J et al. Genetics of gene expression and its effect on disease. Nature 2008; 452: 423-428.
63. Dempfle A, Hinney A, Heinzel-Gutenbrunner M, Raab M, Geller F, Gudermann T et al. Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index. J Med Genet 2004; 41: 795-800.
64. Hegele RA. Lessons from human mutations in PPARgamma. Int J Obes (Lond) 2005; 29 (Suppl 1): S31-S35.
65. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006; 7: 55-65.